1. Drug-eluting and bare metal stents

BP-SES versus DP-EES

TARGET ALL COMERS 5 years
Objective
to report the final 5-year clinical outcomes of PCI with FIREHAWK biodegradable polymer sirolimus-eluting stent (BP-SES) as compared to durable polymer everolimus-eluting stent Xience (DP-EES)
Study
multicentre open-label non-inferiority randomised trial
Population
all-comers
Endpoints
target lesion failure (TLF) as composite of cardiac death, MI or ischaemia-driven target lesion revascularisation at 5 years
Conclusion
PCI in all-comers using BP-SES compared to DP-EES was non-inferior during 5 years follow-up
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved